Exponent’s PhD-led safety consulting franchise is compounding through AI and grid complexity, but a 31.8x forward P/E makes execution and utilization critical.
Overview
Exponent is a specialized engineering and scientific consulting firm serving safety-critical problems for multinational corporations, law firms, insurers and government clients. It operates across approximately thirty offices and derives about 85% of net revenue from Engineering and Other Scientific work, with the balance from Environmental and Health services. Its more than 650 PhD-level professionals, ninety technical disciplines, scientific objectivity and specialized testing infrastructure create a differentiated position versus generalist consultants. **The financial trajectory remains strong:** Q1 FY2026 total revenue rose 14.3% to $166.303 million, net revenue increased 10.5% to $151.817 million, and diluted EPS grew 13.5% to $0.59, beating consensus of $0.57. Full-year guidance calls for high-single-digit net-revenue growth and a 27.6%–28.1% EBITDA margin. The long-term catalyst is proactive consulting tied to AI-integrated products, grid modernization and electrified transportation. However, valuation is demanding at a 31.8x forward P/E, prompting UBS and JP Morgan to reduce targets to $75 and $80. The report views Exponent as a high-quality long-term compounder, but near-term upside is constrained by valuation and utilization sensitivity.